Our results suggest that CYP4F3, ATG7, and PDE4B do not impact the prognosis of patients with CRC, but play a role in influencing the prognosis of patients with CRLM (Supplementary Fig. 1B). This evidence concerns the gene CYP4F3 and colorectal carcinoma.